Nature’s Sunshine Sets Fourth Quarter and Full Year 2022

Nature’s Sunshine Sets Fourth Quarter and Full Year 2022

LEHI, Utah, March 01, 2023 (GLOBE NEWSWIRE) -- Nature’s Sunshine Products, Inc. (Nature’s Sunshine) (NASDAQ: NATR), a leading natural health and wellness......

Sana Biotechnology to Present at the Cowen 43rd Annual

Sana Biotechnology to Present at the Cowen 43rd Annual

[img]https://ml.globenewswire.com/Resource/Download/86b7f0b7-b317-402a-b600-8a26860a948e?size=1[/img]SEATTLE, March 01, 2023 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on creating and delivering engineered cells...

Warner Music Group Corp. to Participate in Morgan Stanley

Warner Music Group Corp. to Participate in Morgan Stanley

NEW YORK, March 01, 2023 (GLOBE NEWSWIRE) -- Warner Music Group Corp. (“Warner Music Group” or “WMG”) announced today that Robert Kyncl, Chief Executive......

ZyVersa Therapeutics to Participate in a Fireside Chat at

ZyVersa Therapeutics to Participate in a Fireside Chat at

CEO Stephen C. Glover to discuss key updates on the development status of ZyVersa’s Phase 2a-ready Cholesterol Efflux Mediator™ VAR 200 for renal disease,......

NGM Bio to Participate in the Cowen 43rd Annual Health Care

NGM Bio to Participate in the Cowen 43rd Annual Health Care

SOUTH SAN FRANCISCO, Calif., March 01, 2023 (GLOBE NEWSWIRE) -- NGM Biopharmaceuticals, Inc. (NGM Bio) (Nasdaq: NGM), a biotechnology company focused on......

Royalty Pharma Appoints Ashwin Pai as Executive Vice

Royalty Pharma Appoints Ashwin Pai as Executive Vice

NEW YORK, March 01, 2023 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced the appointment of Ashwin Pai, M.D. as Executive Vice......

BioNTech Announces Establishment of Interdisciplinary mRNA

BioNTech Announces Establishment of Interdisciplinary mRNA

JERUSALEM, Israel, March 1, 2023 – BioNTech SE (Nasdaq: BNTX, “BioNTech”, “the Company”) announced that the Company and the Weizmann Institute of Science......

Xometry Reports Fourth Quarter and Full Year 2022 Results

Xometry Reports Fourth Quarter and Full Year 2022 Results

Q4 revenue increased 46% year-over-year driven by solid marketplace growth of 32% as well as supplier services including the acquisition of Thomas Q4......

Kineta Appoints Internationally-Renowned Clinical

Kineta Appoints Internationally-Renowned Clinical

SEATTLE, March 01, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on developing next-generation......

Beam Therapeutics to Participate in the 43rd Annual Cowen

Beam Therapeutics to Participate in the 43rd Annual Cowen

CAMBRIDGE, Mass., March 01, 2023 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic......

  • 1
  • ...
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • ...
  • 45
  • menu
    menu